Key result
NSTEMI patients had higher early survival than STEMI patients, but 12-month major adverse cardiac events were not different between the two groups.
Why the study?
Do clinical outcomes differ between patients presenting with NSTEMI versus STEMI in the Korean population?
Cohort (n=13,133)
Yes
Do clinical outcomes differ between patients presenting with NSTEMI versus STEMI in the Korean population?
Answers are grounded in this paper and cite their sources.
In Korea, the incidence of acute myocardial infarction has been increasing rapidly. Twelve-month clinical outcomes for 13,133 patients with acute myocardial infarction enrolled in the nationwide prospective Korea Acute Myocardial Infarction Registry study were analyzed according to the presence or absence of ST-segment elevation. Patients with ST-segment elevation myocardial infarction (STEMI) were younger, more likely to be men and smokers, and had poorer left ventricular function with a higher incidence of cardiac death compared to patients with non-ST-segment elevation myocardial infarction (NSTEMI). NSTEMI patients had a higher prevalence of 3-vessel and left main coronary artery disease with complex lesions, and were more likely to have co-morbidities. The in-hospital and 1-month survival rates were higher in NSTEMI patients than in STEMI patients. However, 12-month survival rates was not different between the two groups. In conclusion, NSTEMI patients have worse clinical outcomes than STEMI patients, and therefore should be treated more intensively during clinical follow-up.
No takes yet. Share an insight, caveat, or question.
Sim et al. (2009) conducted a cohort in Acute myocardial infarction (n=13,133). Non-ST-segment elevation myocardial infarction (NSTEMI) vs. ST-segment elevation myocardial infarction (STEMI) was evaluated on Composite of major adverse cardiac events (MACE), including death from any cause, myocardial infarction, target vessel/lesion revascularization, and coronary artery bypass grafting (CABG) at 12 months (p=0.121). NSTEMI patients had higher early survival than STEMI patients, but 12-month major adverse cardiac events were not different between the two groups.
Synapse has enriched 10 related papers. Consider them for comparative context: